JMP Securities downgraded Deciphera to Market Perform from Outperform after the company entered into an agreement to be acquired by Ono Pharmaceutical for $25.60 per share.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks